|
"tsou hh"的相關文件
顯示項目 61-85 / 109 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2013-12 |
Pharmacogenomics study in a Taiwanese methadone maintenance cohort
|
Wang, SC;Tsou, HH;Ho, IK;Lin, KM;Liu, YL |
| 國家衛生研究院 |
2013-11 |
A 12-Year ecological study of hip fracture rates among older Taiwanese adults
|
Chan, DC;Lee, YS;Wu, YJ;Tsou, HH;Chen, CT;Hwang, JS;Tsai, KS;Yang, RS |
| 國家衛生研究院 |
2013-11 |
Comparison of escitalopram and paroxetine in the treatment of major depressive disorder
|
Lin, HL;Hsu, YT;Liu, CY;Chen, CH;Hsiao, MC;Liu, YL;Shen, WW;Hsiao, CF;Liu, SI;Chang, LH;Tang, HS;Lai, HL;Lin, PS;Lin, KM;Tsou, HH |
| 國家衛生研究院 |
2013-09 |
Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort
|
Wang, SC;Ho, IK;Tsou, HH;Liu, SW;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Liu, SC;Wu, HY;Kuo, HW;Chen, AC;Chang, YS;Liu, YL |
| 國家衛生研究院 |
2013-08-19 |
A consistency approach for evaluation of biosimilar products
|
Tsou, HH;Chang, WJ;Hwang, WS;Lai, YH |
| 國家衛生研究院 |
2013-07-23 |
Hepatitis C Virus infection influences the S-methadone metabolite plasma concentration
|
Wu, SL;Wang, SC;Tsou, HH;Kuo, HW;Ho, IK;Liu, SW;Hsu, YT;Chang, YS;Liu, YL |
| 國家衛生研究院 |
2013-07 |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
|
Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang, YS;Yeh, TK;Chen, AC;Liu, YL |
| 國家衛生研究院 |
2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-05 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
|
Chen, LT;Chen, JS;Chao, Y;Tsai, CS;Shan, YS;Hsu, C;Huang, SF;Tsou, HH;Lee, KD;Chiu, CF;Rau, KM;Ho, CL;Yu, MS;Taiwan Cooperative Oncology Group |
| 國家衛生研究院 |
2013-04 |
Comparing multiple testing correction methods between two softwares for single nucleotide polymorphisms association analyses: Using OPRD1 and diastolic blood pressure in methadone maintenance patients as an example
|
Chang, YS;Tsou, HH;Wang, SC;Fang, CP;Liu, YL;Ho, IK |
| 國家衛生研究院 |
2013-04 |
EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Tang, CK;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-02 |
OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study
|
Chen, YT;Tsou, HH;Kuo, HW;Fang, CP;Wang, SC;Ho, IK;Chang, YS;Chen, CH;Hsiao, CF;Wu, HY;Lin, KM;Chen, ACH;Tsai-Wu, JJ;Liu, YL |
| 臺北醫學大學 |
2013 |
Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY |
| 臺北醫學大學 |
2013 |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
|
Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang |
| 國家衛生研究院 |
2012-10 |
Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients
|
Wang, SC;Tsou, HH;Chen, CH;Chen, YT;Ho, IK;Hsiao, CF;Chou, SY;Lin, YF;Fang, KC;Huang, CL;Su, LW;Fang, YC;Liu, ML;Wu, HY;Lin, KM;Liu, SC;Kuo, HW;Chiang, IC;Chen, AC;Tian, JN;Liu, YL |
| 國家衛生研究院 |
2012-09-25 |
A pilot randomized controlled trial to improve geriatric frailty
|
Chan, DC;Tsou, HH;Yang, RS;Tsauo, JY;Chen, CY;Hsiung, CA;Kuo, K |
| 國家衛生研究院 |
2012-09-04 |
Assessment of regional treatment effect in a multiregional clinical trial
|
Tsong, Y;Chang, WJ;Dong, X;Tsou, HH |
| 國家衛生研究院 |
2012-09 |
Putative tumor metastasis-associated genes in human gastric cancer
|
Tuan, TF;Chung, CT;Tsou, HH;Chen, FW;Lin, HL;Lai, YK;Lee, WS;Chao, YS;Hwang, LL;Chen, CT |
| 國家衛生研究院 |
2012-09 |
Weighted evidence approach of bridging study
|
Tsou, HH;Tsong, Y;Liu, JT;Dong, XY;Wu, YT |
| 國家衛生研究院 |
2012-09 |
Design and analysis issues of multiregional clinical trials with different regional primary endpoints
|
Tsou, HH;Tsong, Y;Chang, WJ;Dong, X;Hsiao, CF |
| 國家衛生研究院 |
2012-07-26 |
Multiregional Clinical Trials
|
Tsong, Y;Tsou, HH |
| 國家衛生研究院 |
2012-07-26 |
A bayesian approach for evaluation of bridging studies
|
Hsiao, CF;Tsou, HH;Liu, JP;Wu, YJ |
| 國家衛生研究院 |
2012-07-26 |
Two-stage designs of bridging studies
|
Hsiao, CF;Tsou, HH;Liu, JP;Wu, YJ |
| 國家衛生研究院 |
2012-07 |
Establishing consistency across all regions in a multi-regional clinical trial
|
Tsou, HH;James Hung, HM;Chen, YM;Huang, WS;Chang, WJ;Hsiao, CF |
| 國家衛生研究院 |
2012-06 |
UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients
|
Tian, JN;Ho, IK;Tsou, HH;Fang, CP;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Chen, YT;Liu, SC;Hsu, YT;Kuo, HW;Liu, CT;Yang, YT;Chen, A;Shih, YH;Liu, YL |
顯示項目 61-85 / 109 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
